Daybue Q2 2024 revenue was $84.6M and represented a recent uncomplicated quarter results.Daybue Q1 2025 results of around $88.0M[in my view] suggests that Acadia has been virtually unable to improve revenue via increased patient numbers or better patient retention/fewer discontinuation numbers etc in the past six months as a buffer against the anticipated Q1 2025 pullback.I would have thought that the new CEO general initiatives and increasing penetration rates should have resulted in improved bottle sales over the last quarter sufficient to cover any potential Q4 2024 sales shortfall.
Kens
Daybue Q2 2024 revenue was $84.6M and represented a recent...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$12.92 |
Change
0.070(0.54%) |
Mkt cap ! $1.607B | |||
| Open | High | Low | Value | Volume |
| $13.15 | $13.37 | $12.85 | $8.049M | 616.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 4175 | $12.91 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.03 | 100 | 1 |
View Market Depth
| Last trade - 16.10pm 18/06/2025 (20 minute delay) ? |
| NEU (ASX) Chart |